An acclaimed life sciences campus in Bridgewater with some 800,000 square feet of research, manufacturing and office space is on the market — with the potential to sell for $500 million.
A brokerage team has identified a California-based investment firm as the buyer in the recent sale of the nearly 675,000-square-foot Sanofi U.S. headquarters campus in Bridgewater.
A real estate investment trust is selling the nearly 675,000-square-foot Sanofi U.S. headquarters campus in Bridgewater for $261 million, in a move that comes as part of its pivot toward a large-scale, necessity-based retail portfolio.
For all the time we’ve spent highlighting New Jersey’s glut of sprawling, vacant corporate campuses, it’s easy to lose sight of just how many of them have been rescued in recent years by some of the state’s boldest and most inventive developers. Those success stories are worth telling, which is why we often do at Real Estate NJ. But there are underlying trends or nuances in some of those projects that don’t get as much attention on a day-to-day basis. Like how a crop of innovative, lesser-known biotech and pharmaceutical firms are backfilling space at the former research campuses of Sanofi and Hoffmann-LaRoche, helping to stabilize those sites as their new owners pursue larger redevelopment plans.